NEW YORK (GenomeWeb News) - Protagen said yesterday that it is partnering with the Center for Applied Proteomics in Germany and Shunde Kangdi Antibody Biotech and the Beijing Proteome Research Center in China to develop antibodies against liver proteins.
Protagen said it will create custom protein biochips for quantitative analysis of binding profiles of antibody candidates. The biochips also will analyze off-target activities of the antibody candidates.
The company, which has offices in Dortmund, Germany, and in Chester, NJ, makes the UniChip line of protein biochips, a biomarker discovery platform, and a platform for protein expression libraries and protein arrays.
The Center for Applied Proteomics, a consortium that includes Ruhr University’s Medical Proteome Center, the University of Dortmund, and the Biomedicine Center Dortmund, will use the biochips to study around 200 monoclonal antibodies made by Shunde Kangdi and Beijing PRC, Protagen said.
Helmut Meyer, head of the Human Brain Proteome Project and director of the Center for Applied Proteomics, said that because the “the proteome is so much more complex than the genome,” and very costly to research, it is “useful to work with a number of partners to draw on a wide range of experience and pool resources.”
Protagen said the partners in the project are sharing worldwide commercialization rights for the antibodies analyzed through the partnership.